Crown (CCK) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Q3 2025 delivered a return to profitability, with diluted EPS of $1.85 versus a loss of $1.47 in Q3 2024, and adjusted EPS up 13% to $2.24 year-over-year.
Net income attributable to shareholders was $214 million for Q3 2025, compared to a loss of $175 million in Q3 2024; nine-month net income was $588 million, up from $66 million year-over-year.
Free Cash Flow for the first nine months rose to $887 million from $668 million, driven by higher income and lower capital spending.
Achieved long-term net leverage target of 2.5x and returned over $400 million to shareholders through buybacks and dividends year-to-date.
The company remains focused on profitable growth, cash flow generation, and shareholder returns.
Financial highlights
Q3 2025 net sales were $3,202 million, up from $3,074 million in Q3 2024, reflecting 12% shipment growth in European beverage, higher raw material cost pass-through, and favorable FX.
Segment Income reached $490 million, up from $472 million in the prior year quarter.
Adjusted EPS was $2.24, up from $1.99 in the prior year quarter; reported EPS was $1.85 versus a loss of $1.47.
Cash from operating activities for the nine months ended September 30, 2025, increased to $1,043 million from $897 million in the prior year.
$314 million of stock repurchased in the nine months ended September 30, 2025.
Outlook and guidance
Full-year 2025 adjusted EPS guidance raised to $7.70–$7.80; Q4 adjusted EPS projected at $1.65–$1.75.
2025 full-year adjusted Free Cash Flow estimated at ~$1 billion after $400 million in capital spending.
Net leverage expected to remain near 2.5x; net interest expense forecast at ~$350 million; tax rate at 25%.
CapEx for 2025 expected at $400 million, with potential increases for expansion projects.
Latest events from Crown
- Q2 adjusted EPS up 19%, guidance raised, and robust share repurchases and cash flow outlook.CCK
Q2 20258 Jul 2026 - Record adjusted EBITDA, strong free cash flow, and robust shareholder returns highlight 2025 results.CCK
Q4 20258 Jul 2026 - Adjusted EPS up 11% and net sales up 13% on strong global beverage can demand and India expansion.CCK
Q1 20261 May 2026 - Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025